BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Rose DU, Cairoli S, Dionisi M, Santisi A, Massenzi L, Goffredo BM, Dionisi-Vici C, Dotta A, Auriti C. Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age. Int J Mol Sci 2020;21:E5898. [PMID: 32824472 DOI: 10.3390/ijms21165898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 De Rose DU, Piersigilli F, Goffredo BM, Danhaive O, Dotta A, Auriti C. Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis. Pathogens 2021;10:890. [PMID: 34358040 DOI: 10.3390/pathogens10070890] [Reference Citation Analysis]
2 Marion D, Caroline S, Renaud V, Romain G. Advocacy for close monitoring of caspofungin therapy in premature infants: A case report. Pediatr Neonatol 2021:S1875-9572(21)00229-1. [PMID: 34896026 DOI: 10.1016/j.pedneo.2021.11.003] [Reference Citation Analysis]
3 Xiao J, Shi J, Li R, Her L, Wang X, Li J, Sorensen MJ, Bhatt-Mehta V, Zhu HJ. Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1179:122865. [PMID: 34365292 DOI: 10.1016/j.jchromb.2021.122865] [Reference Citation Analysis]
4 Muehlbacher T, Bassler D, Bryant MB. Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants. Children (Basel) 2021;8:298. [PMID: 33924638 DOI: 10.3390/children8040298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Singla P, Musyuni P, Aggarwal G, Singh H. Precision Medicine: An Emerging Paradigm for Improved Diagnosis and Safe Therapy in Pediatric Oncology. Cureus 2021;13:e16489. [PMID: 34430104 DOI: 10.7759/cureus.16489] [Reference Citation Analysis]
6 Gaspar VP, Ibrahim S, Zahedi RP, Borchers CH. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine. J Mass Spectrom 2021;56:e4788. [PMID: 34738286 DOI: 10.1002/jms.4788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Joshi G, Kabra A, Goutam N, Sharma A. An Overview on Patient-Centered Clinical Services. Borneo J Pharm 2021;4:157-70. [DOI: 10.33084/bjop.v4i2.1978] [Reference Citation Analysis]
8 Meliota G, Lombardi M, Benevento M, Console V, Ciccone MM, Solarino B, Vairo U. Off-Label Use of Cardiovascular Drugs in the Home Therapy of Children With Congenital or Acquired Heart Disease. Am J Cardiol 2021:S0002-9149(21)01155-3. [PMID: 34952672 DOI: 10.1016/j.amjcard.2021.11.029] [Reference Citation Analysis]
9 Gatti M, Cojutti PG, Campoli C, Caramelli F, Corvaglia LT, Lanari M, Pession A, Ramirez S, Viale P, Pea F. A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings. Front Pharmacol 2021;12:755075. [PMID: 34646143 DOI: 10.3389/fphar.2021.755075] [Reference Citation Analysis]